Latest Breaking News On - Martin dubuc - Page 1 : comparemela.com

Oxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical Use

Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and SeqOne, the leading AI-driven genomic decision support software, today announced a new partnership.

France generalLaurent mesnardOxford nanoporeOxford nanopore technologieGordon sangheraSeqone diagaiMartin dubucProduct serviceCancer foundationResearch partnership programNational centre for thromboticSoftware clubNanopore technologiesSeqone partnerSupport interpretationNanopore sequencing

Easing MS Walking Problems With Music as Therapy May Be Possible

Easing MS Walking Problems With Music as Therapy May Be Possible
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

United statesBrian harrisMartin dubucBiogen digital healthCleveland clinicMassachusetts generalBiogen digital

Biogen and MedRhythms sign deal worth over $120m for digital therapeutics for MS patients

Biogen and MedRhythms sign deal worth over $120m for digital therapeutics for MS patients
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Brian harrisMartin dubucBiogen digital healthRhythmic auditory stimulationBiogen digital

Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis

The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on Rhythmic Auditory Stimulation MedRhythms to receive a $3 million upfront payment. | May 5, 2022

United statesBrian harrisMartin dubucHeinz schallerWalter gilbertCharles weissmannKenneth murrayHead of biogen digital healthBiogen incExchange commissionBiogen digitalChief executive officerSir kenneth murrayNobel prizeHealthy livesBreakthrough device

Biogen Inc : Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis

The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on Rhythmic Auditory Stimulation (RAS)MedRhythms to receive a $3 million upfront payment as

United statesUnited kingdomNorth lanarkshireBrian harrisMartin dubucWalter gilbertCharles weissmannHeinz schallerLauren steidlAshleigh kossMike henckeElvir mujanovicKenneth murrayExchange commissionHead of biogen digital healthRhythmic auditory stimulation